Cureus | PDGFR Inhibitor ARRY-768 Prevents Experimental Dermal Fibrosis and Induces Regression of Pre-Established Dermal Fibrosis

PDGFR Inhibitor ARRY-768 Prevents Experimental Dermal Fibrosis and Induces Regression of Pre-Established Dermal Fibrosis


Abstract

PDGFR inhibitor ARRY-768 prevents experimental dermal fibrosis and induces regression of pre-established dermal fibrosis
Poster
non-peer-reviewed

PDGFR Inhibitor ARRY-768 Prevents Experimental Dermal Fibrosis and Induces Regression of Pre-Established Dermal Fibrosis


Author Information


PDF Share